Committee Membership Information
A Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials
Dr. Jonathan M. Samet
University of Southern California
Jonathan M. Samet (Chair) (IOM) is a pulmonary physician and epidemiologist. He is Professor and Flora L. Thornton Chair for the Department of Preventive Medicine at the Keck School of Medicine at the University of Southern California (USC), and Director of the USC Institute for Global Health. From 1994 through 2008, he was Professor and Chairman of the Department of Epidemiology of the Johns Hopkins Bloomberg School of Public Health. He received an A.B. degree in chemistry and physics from Harvard College, and an M.D. from the University of Rochester School of Medicine and Dentistry. He also has an MS in epidemiology from the Harvard School of Public Health. Dr. Samet has investigated major health issues using epidemiology. His research has focused on the health risks of inhaled pollutants?particles and ozone in outdoor air and indoor pollutants including secondhand smoke and radon. He has also investigated the occurrence and causes of cancer and respiratory diseases, emphasizing the risks of active and passive smoking. He has served as president of the Society for Epidemiologic Research and of the American College of Epidemiology. He has been editor or associate editor for the American Review of Respiratory Disease, the American Journal of Epidemiology, and Epidemiology. He has served on numerous committees concerned with using scientific evidence for the development of policy to protect public health: the Science Advisory Board of the Environmental Protection Agency (EPA); committees of the National Research Council, including chairing the Biological Effects of Ionizing Radiation (BEIR) VI Committee, the Committee on Research Priorities for Airborne Particulate Matter, and the Board on Environmental Studies and Toxicology. He also served on committees of the Institute of Medicine. He currently chairs the Clean Air Scientific Advisory Committee of EPA. Dr. Samet received the Surgeon General?s Medallion in 1990 and 2006, the 2004 Prince Mahidol Award for Global Health awarded by the King of Thailand, and the 2006 Public Service Award of the American Thoracic Society. He received the Alumni Award of Merit from the Harvard School of Public Health, and was named Distinguished Alumnus of the Year by the University of Rochester School of Medicine and Dentistry. He was elected to the Institute of Medicine in 1997.
Dr. Vicki L. Colvin
Vicki L. Colvin is professor of chemistry at Rice University and director of its Center for Biological and Environmental Nanotechnology (CBEN). Among CBEN's primary interests is the application of nanotechnology to the environment. She has received numerous accolades for her teaching abilities, including Phi Beta Kappa's Teaching Prize for 1998-1999 and the Camille Dreyfus Teacher Scholar Award in 2002. In 2002, she was also named one of Discover magazine's "Top 20 Scientists to Watch" and received an Alfred P. Sloan Fellowship. In 2007, she was named a Fellow in the Association for the Advancement of Science (AAAS). Dr. Colvin is a frequent contributor to Advanced Materials, Physical Review Letters, and other peer-reviewed journals and holds patents to seven inventions. Dr. Colvin served on the NRC Committee for Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials. She received her Ph.D. in chemistry from the University of California, Berkeley, where she was awarded the American Chemical Society?s Victor K. LaMer Award for her work in colloid and surface chemistry.
Dr. David B. Warheit
E. I. du Pont de Nemours & Company
David B. Warheit received his Ph.D in physiology from Wayne State University School of Medicine in Detroit. Subsequently, he was awarded a National Institutes of Health (NIH) Postdoctoral Fellowship, and 2 years later, a Parker Francis Pulmonary Fellowship, both of which he took to National Institute of Environmental Health Sciences to study mechanisms of asbestos-related lung disease with Arnold Brody. In 1984, he moved to the DuPont Haskell Laboratory to develop a pulmonary toxicology research laboratory. His major research interests are pulmonary toxicological mechanisms and corresponding risks related to inhaled particulates, fibers and nanomaterials. He is the author/co-author of more than 100 publications and has been the recipient of the International Life Sciences Institute (ILSI) Kenneth Morgareidge Award (1993 - Hannover, Germany) for contributions in Toxicology by a Young Investigator and the Robert A. Scala Award and Lectureship in Toxicology (2000). He has also attained diplomat status of the Academy of Toxicological Sciences (2000) and the American Board of Toxicology (1988). He has served on National Institutes of Health (NIH) review committees (NIH Small Business Innovation Research, NIH Bioengineering) and has participated in working groups at the International Agency for Research on Cancer (IARC), European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC), Organisation for Economic Co-operation and Development (OECD), ILSI Risk Science Institute, ILSI Health and Environmental Sciences Institute and the National Research Council, as well as several journal editorial boards (including current Associate Editor ? Inhalation Toxicology and Toxicological Sciences), Particle and Fibre Toxicology, Toxicology Letters and Nano Letters. Currently he is the chairman of the ECETOC task force on ?Health and Environmental Safety of Nanomaterials,? and serves on the National Institute of Occupational Safety and Health (NIOSH) Board of Scientific Counselors and interim vice-president, Nanotoxicology Specialty Section.
Dr. Philip K. Hopke
Philip K. Hopke is the Bayard D. Clarkson Distinguished Professor in the Department of Chemical and Biomolecular Engineering and the Department of Chemistry at Clarkson University. He is also director of the University?s Center for the Environment and its Center for Air Resources Engineering and Sciences. His research interests are primarily related to particles in the air, including particle formation, sampling and analysis, composition, and origination. His current projects are related to receptor modeling, ambient monitoring, and nucleation. Dr. Hopke has been elected to membership of the International Statistics Institute and he is a fellow of the American Association for the Advancement of Sciences. He is also a fellow of the American Association for Aerosol Research where he has served in various roles, including as president, vice president, and as a member of the board of directors. Dr. Hopke is a member of the American Institute of Chemical Engineers, the International Society of Exposure Science, and the International Society of Indoor Air Quality and Climate, among others. He has served as a member of the U.S. Environmental Protection Agency Advisory Council on Clean Air Act Compliance Analysis and as a member of several National Research Council (NRC) committees. Most recently he was a member of the NRC Committee on Energy Futures and Air Pollution in Urban China and the United States, the Committee on Research Priorities for Airborne Particulate Matter, and the Committee on Air Quality Management in the United States. Dr. Hopke received his Ph.D. in chemistry from Princeton University.
Dr. Gregory V. Lowry
Carnegie Mellon University
Gregory V. Lowry is professor in the Department of Civil and Environmental Engineering at Carnegie Mellon University and deputy director of the National Science Foundation (NSF) Center for Environmental Implications of Nanotechnology (CEINT). He researches sustainable development of nanomaterials and nanotechnologies, including the fate, mobility, and toxicity of nanomaterials in the environment, remediation/treatment technologies employing nanomaterials, and nanoparticle-contaminant/biota interactions. He also works on sustainable energy via carbon capture and storage. His current projects include elucidating the role of adsorbed macromolecules on nanoparticle transport and fate in the environment, in situ sediment management using innovative sediment caps, dense nonaqueous phase liquid (DNAPL) source zone remediation through delivery of reactive nanoparticles to the NAPL-water interface, and carbon dioxide capture, sequestration, and monitoring. Dr. Lowry served as an external advisory board member for CBEN. He was a review panelist for EPA?s Draft Nanomaterial Research Strategy (NRS) and a reviewer of the National Research Council report on ?Review of the Federal Research Strategy for Nanotechnology-Related Environmental, Health, and Safety Research.? He is a member of the American Chemical Society, American Society of Civil Engineers, and the Association of Environmental Engineering and Science Professors, among others. He received his Ph.D. in civil-environmental engineering from Stanford University.
Dr. Richard A. Denison
Environmental Defense Fund
Richard A. Denison is a senior scientist at the Environmental Defense Fund. Dr. Denison has 25 years of experience in the environmental arena, specializing in chemicals policy and hazard, exposure, and risk assessment and management for industrial chemicals and nanomaterials. He currently serves on the Green Ribbon Science Panel for California?s Green Chemistry Initiative. Until recently, Dr. Denison was a member of the National Pollution Prevention and Toxics Advisory Committee, which advised EPA?s toxics office. He is a member of the NRC Board on Environmental Studies and Toxicology. Previously, Dr. Denison was an analyst and assistant project director in the Oceans and Environment Program, Office of Technology Assessment, United States Congress. Dr. Denison received his Ph.D. in Molecular Biophysics and Biochemistry from Yale University.
Dr. Mark J. Utell
University of Rochester School of Medicine and Dentistry
Mark J. Utell is professor of Medicine and Environmental Medicine, a director of Occupational and Environmental Medicine and former director of Pulmonary and Critical Care Medicine at the University of Rochester Medical Center. He serves as associate chairman of the Department of Environmental Medicine. His research interests have centered on the effects of environmental toxicants on the human respiratory tract. Dr. Utell has published extensively on the health effects of inhaled gases, particles and fibers in the workplace and other indoor and outdoor environments. He is the co-principal investigator of an EPA Particulate Matter Center and chair of the Health Effects Institute?s Research Committee. He has served as chair of EPA?s Environmental Health Committee and on the Executive Committee of the EPA Science Advisory Board. He is a former recipient of the National Institute of Environmental Health Sciences Academic Award in Environmental and Occupational Medicine. Dr. Utell is currently a member of the National Research Council?s (NRC) Board on Environmental Studies and Toxicology. He previously served on the NRC Committee on Research Priorities for Airborne Particulate Matter, the Institute of Medicine's (IOM) Committee to Review the Health Consequences of Service during the Persian Gulf War; and the IOM Committee on Biodefense Analysis and Counter-measures. He received his M.D. from Tufts University School of Medicine.
Dr. Mark R. Wiesner
Mark R. Wiesner serves as director of the Center for the Environmental Implications of Nanotechnology (CEINT) headquartered at Duke University, where he holds the James L. Meriam Chair in Civil and Environmental Engineering with appointments in the Pratt School of Engineering and the Nicholas School of Environment. Dr. Wiesner?s research has focused on the applications of emerging nanomaterials to membrane science and water treatment and an examination of the fate, transport, and impacts of nanomaterials in the environment. He co-edited/authored the book ?Environmental Nanotechnologies? and serves as associate editor of the journals Nanotoxicology and Environmental Engineering Science. Before joining the Duke University faculty in 2006, Professor Wiesner was a member of the Rice University faculty for 18 years where he held appointments in the Departments of Civil and Environmental Engineering and Chemical Engineering and served as associate dean of Engineering, and director of the Environmental and Energy Systems Institute. Prior to working in academia, Dr. Wiesner was a research engineer with the French company, the Lyonnaise des Eaux, in Le Pecq, France, and a principal engineer with the environmental engineering consulting firm of Malcolm Pirnie, Inc., White Plains, NY. Wiesner received the1995 Rudolf Hering medal from the American Society of Civil Engineers and the 2004 Frontiers in Research Award from the Association of Environmental Engineering and Science Professors. In 2004 Dr. Wiesner was also named a ?de Fermat Laureate? and was awarded an International Chair of Excellence at the Chemical Engineering Lab of the French Polytechnic Institute and National Institute for Applied Sciences in Toulouse, France. Professor Wiesner is a fellow of the American Society of Civil Engineers and serves on the Board of the Association of Environmental Engineering and Science Professors. Dr. Wiesner received his Ph.D. in environmental engineering from the Johns Hopkins University.
Dr. Andrew D. Maynard
University of Michigan School of Public Health
Andrew D. Maynard is the Director of the Risk Science Center at the University of Michigan, School of Public Health. He previously served as the chief science advisor at the Woodrow Wilson International Center for Scholars for the Project on Emerging Nanotechnologies. Dr. Maynard?s research interests revolve around the fields of aerosol characterization, the implications of nanotechnology to human health and the environment, and managing the challenges and opportunities of emerging technologies. Dr. Maynard?s expertise covers many facets of risk science, emerging technologies, science policy and communication. Previously, he worked for NIOSH and represented the agency on the Nanomaterial Science, Engineering and Technology subcommittee of the National Science and Technology Council (NSET), and co-chaired the Nanotechnology Health and Environment Implications (NEHI) working group of NSET. He serves on the World Economic Forum Global Agenda Council on Emerging Technologies and is a member of the Executive Committee of the International Council on Nanotechnology (ICON). He previously chaired the International Standards Organization Working Group on size-selective sampling in the workplace. Dr. Maynard served as a member of the NRC Committee for Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials. He earned his Ph.D. in aerosol physics from the Cavendish Laboratory, University of Cambridge, UK.
Dr. Jurron Bradley
Jurron Bradley is a senior analyst at Lux Research. He leads the Lux Nanomaterials Intelligence practice to provide clients with strategic advice on technology and market trends and themes. Before joining Lux Research, Dr. Bradley worked at Praxair, Inc. where he designed air separation and argon recycle plants and managed a thermodynamics lab. He also led research efforts to reduce mercury emissions from coal-fired boilers and worked on the development of technology to reduce emissions of nitrogen oxides from coal-fired boilers. Dr. Bradley later joined Praxair?s technology planning and strategy group where he played a key role in developing strategic approaches for the entire research and development organization. Dr. Bradley received a Ph.D. in chemical engineering from the Georgia Institute of Technology.
Dr. Edward D. Crandall
University of Southern California
Edward D. Crandall is the Hastings Professor and Kenneth T. Norris, Jr. Chair of Medicine, and Chair, Division of Pulmonary and Critical Care Medicine at the Keck School of Medicine of the University of Southern California. Dr. Crandall?s clinical interests include critical care medicine and pulmonary disease. He has authored numerous peer-reviewed articles on cardiopulmonary biology. His specific research interests are in the regulation of the differentiation and transport properties of alveolar epithelial cells. He is actively involved in research on the interactions of nanomaterials with alveolar epithelium. Dr. Crandall received his Ph.D. from Northwestern University and his M.D. from the University of Pennsylvania.
Dr. Martin A. Philbert
University of Michigan School of Public Health
Martin A. Philbert is a professor of toxicology and senior associate dean for research at the University of Michigan School of Public Health. His research focuses on the development of flexible polymer nanoplatforms for optical sensing of ions and small molecules and the early detection and treatment of brain tumors. Other research interests include the mitochondrial mechanisms of chemically-induced neuropathic states. Dr. Philbert served as the vice chair of the National Research Council Committee for the Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials and chaired the FDA Science Board Committee on Bisphenol A. Dr. Philbert served on the National Advisory Environmental Health Council of the National Institute of Environmental Health Sciences and provides consultation to Federal agencies on a variety of issues surrounding emerging nanotechnologies. He is a standing member of the US FDA Science Advisory Board and the US EPA Board of Scientific Counselors. He earned his Ph.D. in neurochemistry and experimental neuropathology from the University of London.
Dr. Seth Coe-Sullivan
QD Vision, Inc.
Seth Coe-Sullivan is the co-founder and Chief Technology Officer of QD Vision. His work spans quantum dot materials, new fabrication techniques, including thin film deposition equipment design, and device architectures for efficient QD-LED light emission. Seth has more than 20 papers and patents pending in the fields of organic light emitting devices, quantum dot LEDs, and nanotechnology fabrication. He was awarded Technology Review Magazine?s TR35 Award in 2006, naming him one of the top 35 innovators under the age of 35. In 2007, BusinessWeek named him one of the top young entrepreneurs under the age of 30, and in 2009 he was a finalist for the Mass Technology Leadership Council's CTO of the year. Dr. Coe-Sullivan serves on Brown University?s Engineering Advisory Council. He received his Ph.D. in Electrical Engineering from the Massachusetts Institute of Technology; his thesis work on incorporating quantum dots into hybrid organic/inorganic LED structures led to the formation of QD Vision.
Dr. James E. Hutchison
University of Oregon
James E. Hutchison is the Lokey-Harrington Professor of Chemistry at the University of Oregon. He is the founding director of the Oregon Nanoscience and Microtechnologies Institute for Safer Nanomaterials and Nanomanufacturing Initiative, a virtual center that unites 30 principal investigators across the northwest around the goals of designing greener nanomaterials and nanomanufacturing. Dr. Hutchison?s research focuses on molecular-level design and synthesis of functional surface coatings and nanomaterials for a wide range of applications, where the design of new processes and materials draws heavily on the principles of green chemistry. Dr. Hutchison received several awards and honors including the Alfred P. Sloan Research Fellowship and the NSF CAREER Award. He was a member of the NRC Committee on Grand Challenges for Sustainability in the Chemistry Industry. Dr. Hutchison received his Ph.D. in organic chemistry from Stanford University.
Dr. Martin Fritts
SAIC - Frederick, Inc.
Martin Fritts is a Senior Principal Scientist who supports the Nanotechnology Characterization Laboratory and SAIC-Frederick in accelerating the transition of nanotechnology to cancer and biomedical applications. He is also a computational and experimental physicist who works on the implementation of advanced imaging and measurement instrumentation, modeling and simulation to elucidate the structure-activity relationships of nanomaterials, and informatics systems to advance knowledge sharing. Dr. Fritts also serves as the cochair of ASTM's E56.02 Subcommittee on Nanotechnology Characterization. Prior to joining SAIC-Frederick, he developed and prototyped nanotechnology applications for industry and government through SAIC's Nanotechnology Initiatives Division. He earned a Ph.D. in nuclear physics from Yale University.
Dr. Tina Bahadori
American Chemistry Council
Tina Bahadori is the Managing Director for the Long-Range Research Initiative (LRI) program at the American Chemistry Council (ACC). She is responsible for the direction of the LRI, which sponsors a multi-million dollar independent research program that advances the science of risk assessment for the health and ecological effects of chemicals to support decision-making by government, industry, and the public. Dr. Bahadori is the President of the International Society of Exposure Science (ISES) and an Associate Editor of the Journal of Exposure Science and Environmental Epidemiology (JESEE). She has served as a member of several committees of the National Academies; peer reviewer for the US EPA grants and programs; a member of the Chemical Exposure Working Group on the National Children?s Study; and a member of the CDC NCEH/ATSDR National Conversation on Public Health and Chemical Exposure Leadership Council. Prior to joining the American Chemistry Council, she was the Manager, Air Quality Health Integrated Programs, at the Electric Power Research Institute (EPRI). Dr. Bahadori holds a doctorate in Environmental Science and Engineering from the Harvard School of Public Health.
Dr. William H. Farland
Colorado State University
William H. Farland is the Vice President for Research at Colorado State University and a professor in its Department of Environmental and Radiological Health Sciences, School of Veterinary Medicine and Biomedical Sciences. In 2006, Dr. Farland was appointed Deputy Assistant Administrator for Science in EPA?s Office of Research and Development (ORD). He had served as the Acting Deputy Assistant Administrator since 2001. In 2003, Dr. Farland was also appointed Chief Scientist in the Office of the Agency Science Advisor. He served as EPA's Acting Science Advisor throughout 2005. Formerly, he was the Director of the ORD's National Center for Environmental Assessment. Dr. Farland served on a number of executive-level committees and advisory boards within the Federal government. In 2005-2006, he chaired the Executive Committee of the National Toxicology Program (NTP). He was also a member of the Scientific Advisory Council of the Risk Sciences and Public Policy Institute, Johns Hopkins University School of Hygiene and Public Health; a public member of the American Chemistry Council's Strategic Science Team for its Long-Range Research Initiative, and a member of the Programme Advisory Committee for the WHO's International Programme on Chemical Safety. Dr. Farland recently served as Chair of an External Advisory Group for the National Institute of Environmental Health Sciences (NIEHS) regarding the future of the Superfund Basic Research Program. He is also a member of a standing committee on Emerging Science for Environmental Health Decisions of the National Research Council. In 2002, Dr. Farland was recognized by the Society for Risk Analysis with the "Outstanding Risk Practitioner Award," and in 2005 was appointed as a Fellow of the Society. In 2006, he received a Presidential Rank Award for his service as a federal senior executive. In 2007, he was elected as a fellow of the Academy of Toxicological Sciences. Dr. Farland received his Ph.D. from the University of California at Los Angeles in Cell Biology and Biochemistry.
Dr. Gunter Oberdorster
University of Rochester School of Medicine and Dentistry
G�nter Oberd�rster is a professor in the Department of Environmental Medicine at the University of Rochester; director of the University of Rochester Ultrafine Particle Center; principal investigator of a Multidisciplinary Research Initiative in Nanotoxicology; and head of the Pulmonary Core of the National Institute of Environmental Health Sciences Center Grant. His research includes the effects and underlying mechanisms of lung injury induced by inhaled non-fibrous and fibrous particles, including extrapolation modeling and risk assessment. His studies with ultrafine particles influenced the field of inhalation toxicology, raising awareness of the unique biokinetics and toxicological potential of nano-sized particles. He has served on many national and international committees and is recipient of several scientific awards. Dr. Oberd�rster has served on several NRC committees, including the Committee on Research Priorities for Airborne Particulate Matter and the Committee on the Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials. He is on the editorial boards of the Journal of Aerosol Medicine; Particle & Fibre Toxicology; Nanotoxicology; International J. Hygiene & Environmental Health; and Associate Editor of Inhalation Toxicology and Environmental Health Perspectives. He earned his D.V.M. and Ph.D. (Pharmacology) from the University of Giessen in Germany.
Dr. Kathleen M. Rest
Union of Concerned Scientists
Kathleen M. Rest is the executive director of the Union of Concerned Scientists (UCS), a science based non-profit working for a healthy environment and a safer world. She manages the organization's day-to-day affairs, supervising all program departments on issues ranging from climate change and clean energy to global security. Dr. Rest came to UCS from the National Institute for Occupational Safety and Health (NIOSH) in the Centers for Disease Control and Prevention (CDC), where she was the deputy director for Programs. Throughout her tenure at NIOSH, she held several leadership positions including serving as the Institute's acting director over the period of September 11, 2001 and the anthrax events that followed. Prior to her federal service, Dr. Rest spent many years on the faculty at several medical schools?most recently as an associate professor in the Department of Family and Community Medicine at the University of Massachusetts Medical Center and an adjunct associate professor at the University of Massachusetts School of Public Health?where she taught occupational, environmental, and public health. She has extensive experience as a researcher and advisor on occupational and environmental health issues in countries such as the Netherlands, Slovakia, Poland, Romania, Canada, and Greece. Dr. Rest was a founding member of the Association of Occupational and Environmental Clinics (AOEC), a national nonprofit organization committed to improving the practice of occupational and environmental health through information sharing and collaborative research. She also served as the chairperson of the National Advisory Committee on Occupational Safety and Health (NACOSH). Dr. Rest earned her Ph.D. in health policy from Boston University.
Dr. Rebecca D. Klaper
Great Lakes WATER Institute
Rebecca D. Klaper is a Shaw Associate Scientist at the Great Lakes WATER Institute, University of Wisconsin-Milwaukee. The WATER Institute is an organization dedicated to providing basic and applied research to inform policy decisions involving freshwater resources. Dr. Klaper studies the potential impact of emerging contaminants, such as nanoparticles and pharmaceuticals, on aquatic organisms using traditional toxicological methods as well as genomic technologies. Dr. Klaper received a AAAS-Science and Technology Policy Fellowship where she worked in the National Center for Environmental Assessment at EPA. She has served as an invited scientific expert to both the U.S. National Nanotechnology Initiative and the Organization for Economic and Cooperative Development panel on nanotechnology where she has testified on the potential impact of nanoparticles on the environment and the utility of current testing strategies. She has served as a technical expert in reviewing the EPA White Paper on the environmental impact of nanotechnologies and the EPA research strategy for nanotechnology. She also was involved in writing the EPA White Paper on the use of genomic technologies in risk assessment. Dr. Klaper received her Ph.D. in Ecology from the Institute of Ecology, University of Georgia.